United States · FDA National Drug Code directory
Lorazepam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-225_15ea852c-5478-544b-e063-6394a90a1ac5
- Product NDC
- 71610-225
- Form
- TABLET
- Composition / generic term
- Lorazepam
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230516
- Source listing expiry
- 20261231
Source-listed ingredients
- LORAZEPAM — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 TABLET in 1 BOTTLE (71610-225-10) · 71610-225-10
- 15 TABLET in 1 BOTTLE (71610-225-15) · 71610-225-15
- 20 TABLET in 1 BOTTLE (71610-225-20) · 71610-225-20
- 28 TABLET in 1 BOTTLE (71610-225-28) · 71610-225-28
- 30 TABLET in 1 BOTTLE (71610-225-30) · 71610-225-30
- 45 TABLET in 1 BOTTLE (71610-225-45) · 71610-225-45
- 60 TABLET in 1 BOTTLE (71610-225-53) · 71610-225-53
- 90 TABLET in 1 BOTTLE (71610-225-60) · 71610-225-60
- 120 TABLET in 1 BOTTLE (71610-225-70) · 71610-225-70
- 150 TABLET in 1 BOTTLE (71610-225-75) · 71610-225-75
- 180 TABLET in 1 BOTTLE (71610-225-80) · 71610-225-80
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →